Abstract
The existence of an HIV-1 protein translated from an antisense transcript was suggested over 25 years ago. However, this Antisense Protein (ASP) gene has still not been completely accepted by the HIV-1 research community. The aim of this review is to discuss recent findings, which suggest that ASP needs to be considered as a viral gene, playing an important role in HIV-1 replication and persistence. In past years, several studies have highlighted the existence of HIV-1 antisense transcripts. More recently, we and others have convincingly demonstrated that this transcript produces a protein with a unique distribution and a rapid turnover, when expressed in mammalian cells. Furthermore, a role in autophagy and HIV-1 replication has been associated with this protein. In light of these recent reports, we believe that ASP needs to be added to the schematic representation of the HIV-1 proviral DNA and requires further investigation, as it could represent a new potential target for anti-retroviral therapies and vaccine strategies.
Keywords: Antisense Protein, Antisense transcription, Autophagy, HIV-1.
Current HIV Research
Title:Reviving an Old HIV-1 Gene: The HIV-1 Antisense Protein
Volume: 13 Issue: 2
Author(s): Cynthia Torresilla, Jean-Michel Mesnard and Benoit Barbeau
Affiliation:
Keywords: Antisense Protein, Antisense transcription, Autophagy, HIV-1.
Abstract: The existence of an HIV-1 protein translated from an antisense transcript was suggested over 25 years ago. However, this Antisense Protein (ASP) gene has still not been completely accepted by the HIV-1 research community. The aim of this review is to discuss recent findings, which suggest that ASP needs to be considered as a viral gene, playing an important role in HIV-1 replication and persistence. In past years, several studies have highlighted the existence of HIV-1 antisense transcripts. More recently, we and others have convincingly demonstrated that this transcript produces a protein with a unique distribution and a rapid turnover, when expressed in mammalian cells. Furthermore, a role in autophagy and HIV-1 replication has been associated with this protein. In light of these recent reports, we believe that ASP needs to be added to the schematic representation of the HIV-1 proviral DNA and requires further investigation, as it could represent a new potential target for anti-retroviral therapies and vaccine strategies.
Export Options
About this article
Cite this article as:
Torresilla Cynthia, Mesnard Jean-Michel and Barbeau Benoit, Reviving an Old HIV-1 Gene: The HIV-1 Antisense Protein, Current HIV Research 2015; 13 (2) . https://dx.doi.org/10.2174/1570162X12666141202125943
DOI https://dx.doi.org/10.2174/1570162X12666141202125943 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV Vaccine Development.
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
Lymphomas in People Living with HIV (PLWH)
In the era of combined antiretroviral therapy (cART), the incidence of lymphoma among people living with HIV (PLWH) surpassed Kaposi's sarcoma in 2011, becoming the most common AIDS-defining malignancy. The annual incidence rate ranges approximately from 100 to 300 per 100,000 individuals with HIV infection as the population denominator, which ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical and Enzymatic Synthesis of Nucleoside Tetraphosphates
Current Organic Chemistry Importance of Amino Acids, Gln-119 and Tyr-376, in the S1 Pocket of Escherichia coli Peptidase N in Determining Substrate Specificity
Protein & Peptide Letters Contrast Medium Induced Nephropathy: New Insights into Prevention and Risk Management
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy Synthesis, Hydrolysis Kinetics and Pharmacological Evaluation of Aceclofenac Prodrugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Telomere Shortening Is a Sole Mechanism of Aging in Mammals
Current Aging Science Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Is There An Association Between Vitamin D and Hypertension?
Recent Patents on Cardiovascular Drug Discovery Contribution of Transcriptome to Elucidate the Biology of Plasmodium spp
Current Topics in Medicinal Chemistry Down with the Erythropoietin. Long Live the Erythropoietin !
Current Drug Targets Breaking the Skin Barrier: Achievements and Future Directions
Current Pharmaceutical Design Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography/Mass Spectrometry
Central Nervous System Agents in Medicinal Chemistry The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Current Pharmaceutical Design “Care-Getting”: A Conceptual Model of Marshalling Support Near the End of Life
Current Aging Science Role of Acetylcholinesterase Inhibitors in the Metabolism of Amyloid Precursor Protein
Current Drug Targets - CNS & Neurological Disorders Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
Current Pharmaceutical Design Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design 2-Arylquinazolin-4(3H)-ones: Inhibitory Activities Against Xanthine Oxidase
Medicinal Chemistry